SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Enterprises’ arm approves acquisition of CCPL from Navin Fluorine International

29 Oct 2020 Evaluate

Piramal Enterprises’ subsidiary company -- Piramal Pharma (PPL) has approved the acquisition of additional 3,43,04,900 equity shares of the face value of Rs 10 each of Convergence Chemicals (CCPL) for an aggregate cash consideration of Rs 65.10 crore from Navin Fluorine International. Consequent to this Acquisition, CCPL would become a wholly owned subsidiary of PPL. The Acquisition is likely to be completed by January 31, 2021.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×